NCT06527872View on ClinicalTrials.gov

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

RecruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

October 4, 2024

Primary Completion Date

March 29, 2029

Study Completion Date

March 29, 2029

Conditions

Lupus Nephritis

Interventions

OTHER

None (Observational study)

Not Applicable since Observational Study

Trial Locations (1)

28207

RECRUITING

GSK Investigational Site, Charlotte

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY